231 related articles for article (PubMed ID: 11507084)
1. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
Hu X; Janssen WE; Moscinski LC; Bryington M; Dangsupa A; Rezai-Zadeh N; Babbin BA; Zuckerman KS
Cancer Res; 2001 Aug; 61(16):6290-6. PubMed ID: 11507084
[TBL] [Abstract][Full Text] [Related]
2. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
3. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.
Alpert D; Schwenger P; Han J; Vilcek J
J Biol Chem; 1999 Aug; 274(32):22176-83. PubMed ID: 10428782
[TBL] [Abstract][Full Text] [Related]
4. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
5. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
[TBL] [Abstract][Full Text] [Related]
6. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
7. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori.
Keates S; Keates AC; Warny M; Peek RM; Murray PG; Kelly CP
J Immunol; 1999 Nov; 163(10):5552-9. PubMed ID: 10553083
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
10. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide.
Ropert C; Almeida IC; Closel M; Travassos LR; Ferguson MA; Cohen P; Gazzinelli RT
J Immunol; 2001 Mar; 166(5):3423-31. PubMed ID: 11207300
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
Manna SK; Mukhopadhyay A; Aggarwal BB
J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages.
Koch A; Giembycz M; Ito K; Lim S; Jazrawi E; Barnes PJ; Adcock I; Erdmann E; Chung KF
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):342-9. PubMed ID: 12871851
[TBL] [Abstract][Full Text] [Related]
13. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils.
Wong CK; Zhang JP; Ip WK; Lam CW
Clin Exp Immunol; 2002 Jun; 128(3):483-9. PubMed ID: 12067303
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
[TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism.
Meja KK; Seldon PM; Nasuhara Y; Ito K; Barnes PJ; Lindsay MA; Giembycz MA
Br J Pharmacol; 2000 Nov; 131(6):1143-53. PubMed ID: 11082122
[TBL] [Abstract][Full Text] [Related]
17. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes.
Scheller C; Sopper S; Ehrhardt C; Flory E; Chen P; Koutsilieri E; Ludwig S; ter Meulen V; Jassoy C
Eur J Immunol; 2002 Sep; 32(9):2471-80. PubMed ID: 12207331
[TBL] [Abstract][Full Text] [Related]
18. Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase.
Bowie AG; O'Neill LA
J Immunol; 2000 Dec; 165(12):7180-8. PubMed ID: 11120850
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
20. Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways.
Wesselborg S; Bauer MK; Vogt M; Schmitz ML; Schulze-Osthoff K
J Biol Chem; 1997 May; 272(19):12422-9. PubMed ID: 9139689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
